Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Hypoxia”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Post-approval studies (Phase 4)UnknownNCT06115421
What this trial is testing

Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients

Who this might be right for
Anemia in Dialysis-dependent CKD Patients
Alexandria University 72
Large-scale testing (Phase 3)Study completedNCT02648347
What this trial is testing

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Who this might be right for
AnemiaNon-Dialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 1,751
Not applicableStudy completedNCT03941015
What this trial is testing

Tissue Oxygenation During Treatment of Infant Congenital Heart Defects

Who this might be right for
Acute Kidney InjuryHypoxia-Ischemia, BrainMesenteric Ischemia
Beijing Anzhen Hospital 245
Large-scale testing (Phase 3)WithdrawnNCT05082584
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Not applicableStudy completedNCT05495607
What this trial is testing

Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Who this might be right for
Hypoxic-Ischemic EncephalopathySepsisKidney Diseases+4 more
Centre Hospitalier Universitaire de Nice 25
Early research (Phase 1)Study completedNCT01497444
What this trial is testing

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney CancerLiver Cancer
Alliance for Clinical Trials in Oncology 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05239728
What this trial is testing

Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,800
Early research (Phase 1)Active Not RecruitingNCT05030506
What this trial is testing

Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05468697
What this trial is testing

Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 60
Very early researchStudy completedNCT00884520
What this trial is testing

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

Who this might be right for
Lung CancerSquamous Cell CarcinomaHead and Neck Cancer+2 more
Siemens Molecular Imaging 16
Not applicableUnknownNCT03897920
What this trial is testing

Doppler Ultrasound Renal Arterial Resistive Indices As Predictor Of Multiorgan Failure In Patients With Acute Hypoxic Respiratory Failure Admitted To Respiratory Intensive Care Unit (Cryptic Shock Index- RICU)

Who this might be right for
Respiratory FailureMulti Organ Failure
University of Modena and Reggio Emilia 30
Not applicableUnknownNCT04079829
What this trial is testing

Postoperative Respiratory Abnormalities

Who this might be right for
Respiratory FailureRespiratory ArrestRespiratory Distress Syndrome+15 more
Efficacy Care R&D Ltd 50,000
Not applicableLooking for participantsNCT07136792
What this trial is testing

Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)

Who this might be right for
Renal Anemia of Chronic Kidney Disease
Guangdong Provincial People's Hospital 96
Not applicableStudy completedNCT01674465
What this trial is testing

Role of Nox2 in CNI-induced Renal Fibrosis

Who this might be right for
Kidney Disease
University of Wisconsin, Madison 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536804
What this trial is testing

Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Who this might be right for
OverweightObesityChronic Kidney Disease+2 more
Eli Lilly and Company 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT03634540
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Who this might be right for
Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)Kidney Cancer+6 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 118
Not applicableLooking for participantsNCT05008276
What this trial is testing

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseAdolescent Obesity+3 more
Petter Bjornstad 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07262060
What this trial is testing

Improving Preterm Kidney Outcomes With Caffeine

Who this might be right for
Kidney InjuryPre-Term
University of Wisconsin, Madison 114
Post-approval studies (Phase 4)Not Yet RecruitingNCT07162090
What this trial is testing

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

Who this might be right for
SarcopeniaAnemia Associated With Chronic Kidney Disease (CKD)Dialysis Patients
Tianjin Medical University General Hospital 60
Large-scale testing (Phase 3)Active Not RecruitingNCT07000149
What this trial is testing

Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
AstraZeneca 1,116
Load More Results